Posts Tagged ‘Health’
« Older Entries | Newer Entries »
Prioritizing fundamental human rights can help us find the clarity we need for good public policy
Thursday, June 27th, 2019
Ultimately, good public policy requires balancing social, economic, fiscal and political considerations. We can get clarity on the best path to pursue if we decide that future public policies prioritize and articulate the dignities and rights that we think all Canadians should be afforded by virtue of being a human being, and not because of where we work.
Tags: economy, featured, Health, ideology, participation, pharmaceutical, rights, standard of living
Posted in Governance Policy Context | No Comments »
Should there be ‘presumed consent’ for organ donations?
Wednesday, June 26th, 2019
Yes – Ontario, with these things in place, has seen donation rates double to 25 donors per million (DPM). Could an “opt-out” approach help Canada get from a donor rate of 22 DPM toward 40 DPM, the rates in the most successful countries in the world? / No – loosening permission requirements around donation could strike the more circumspect among us as too much boundary revision, too fast, with too little accountability.
Tags: Health, ideology, jurisdiction, participation, rights
Posted in Health Policy Context | No Comments »
To bolster health, would basic income — not pharmacare — make more sense?
Tuesday, June 25th, 2019
… shouldn’t the priority of policy-makers be to ensure that all Canadians can afford necessities such as food and housing, not just prescription drugs? … Affordable sickness care is important, especially if you’re sick. But the way to keep people healthier longer is to ensure that they have a decent income, a roof over their heads, healthy food, a good education, a sound physical environment and sense of belonging.
Tags: economy, Health, ideology, mental Health, participation, pharmaceutical, poverty, standard of living
Posted in Health Debates | No Comments »
Yes, to national pharmacare – because we already paid for it
Tuesday, June 25th, 2019
We are paying, in effect, three times: through federal research grants, through disease-focused charities, and then at the pharmacy. A national pharmacare program could change this if… the cost of a drug over the life of its patent was calculated to recognize the public support its development received. Manufacturers would submit a funding history with a tentative pricing. A fair rate of return would be permitted for the life of a patent based on that information.
Tags: budget, Health, jurisdiction, mental Health, pharmaceutical
Posted in Health Debates | No Comments »
The Ontario government is wrong to offload autism services onto families
Monday, June 24th, 2019
If the health and well-being of children with autism are really the priority here, then the government should build a needs-based autism service program; invest in the human capital of experts and families with lived experience; utilize available public infrastructure and capacity at regional centres; coordinate services and supports across systems; and bring all of these pieces together by helping guide children and families along their journey toward the best life possible
Tags: disabilities, Health, ideology, mental Health, youth
Posted in Child & Family Delivery System | No Comments »
Why universal pharmacare will help get Canada’s drug costs under control — and why Big Pharma hates it
Saturday, June 22nd, 2019
It might be more accurate to say we can’t afford to go without it… The Hoskins report estimates an annual savings of about $5 billion in total drug spending once universal pharmacare is fully implemented… And it would strengthen employers’ ability to hire and properly compensate employees. Employer contributions to drug plans generally reduce worker pay.
Tags: economy, featured, Health, ideology, jurisdiction, mental Health, pharmaceutical, standard of living, tax
Posted in Health Debates | No Comments »
Why are we forever chasing the dream of a universal drug plan?
Tuesday, June 18th, 2019
… derailed by opposing political agendas, fierce resistance from private insurers, public ambivalence and voter apathy… universal pharmacare isn’t merely about equity and ideology, but efficacy and efficiency… The challenge is to make those savings feel real, not notional… that cost-benefit tradeoff must be spelled out clearly to persuade people that the savings end up in their pockets.
Tags: budget, Health, ideology, jurisdiction, mental Health, participation, pharmaceutical, standard of living, tax
Posted in Health Policy Context | No Comments »
Report goes all in on pharmacare, and that may be a mistake
Saturday, June 15th, 2019
The bottom line is that Canada’s inconsistent drug coverage can’t be fixed without government intervention of some kind. That includes lowering the nation’s drug bill by creating a government system of bulk purchases, limiting drug co-pays and regulating premiums.
Tags: budget, Health, ideology, jurisdiction, mental Health, pharmaceutical, standard of living
Posted in Health Policy Context | No Comments »
Five decades in the making, our national pharmacare still has a long way to go
Friday, June 14th, 2019
Canada should take a leap forward here and look to include in a national formulary not only with the most important medicines, but the most important medical devices. The secret sauce in all of this will be smart, strategic negotiations on behalf of all Canadians with drug and device manufacturers to reward real breakthroughs and the backbone to say no to coverage for drugs and devices that just don’t deliver on value for money.
Tags: budget, Health, ideology, jurisdiction, participation, pharmaceutical, standard of living
Posted in Health Policy Context | No Comments »
Putting values into practice on pharmacare will come at a cost
Friday, June 14th, 2019
The catch is that there would be a massive shift of drug costs from private plans to public plans, an “incremental public cost” of $15.3-billion… Practically, it also means the feds would have to raise taxes by at least $15-billion a year. That, not poor values, is the single biggest impediment to national pharmacare. The other related hurdle is that a national plan would require an unprecedented level of federal-provincial-territorial co-operation.
Tags: budget, economy, featured, Health, ideology, jurisdiction, mental Health, participation, pharmaceutical, standard of living, tax
Posted in Health Policy Context | No Comments »
Recent Comments